Dow Down 0.25% Nasdaq Down 0.26%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.78 0.45(5.47%) Aug 28, 4:00PM EDT
Prev Close:8.23
Open:8.00
Bid:2.68 x 100
Ask:8.87 x 800
1y Target Est:11.33
Beta:2.8
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:7.69 - 8.23
52wk Range:3.84 - 8.46
Volume:2,190,619
Avg Vol (3m):671,188
Market Cap:470.24M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSDown 5.47%470.24M
AZN93.77B
PFE186.29B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):62.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback